Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly
Clinical trial NCT05398926 · COMPLETED
Trial details
- NCT number
- NCT05398926
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2022-06-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.